7211
EASI Access II — Follow-up Study to the EASI Access Trial
Condition(s):Disaster Medicine; Difficult Intravenous Access; DehydrationLast Updated:September 11, 2009Completed
First in Human: 7278 Clinical Trials, Page 722 of 728
Hide Studies Not Open or Pending
7212
Multi-center Application of an AI System for Diagnosis of Cervical Lesions Based on Colposcopy Images
Condition(s):Artificial Intelligence; Colposcopy; Cervical Lesions; ImageLast Updated:March 16, 2022Recruiting
7213
Live Birth After Fresh Embryo Transfer Vs Frozen-thawed Embryo Transfer in Women With Polycystic Ovary Syndrome
Condition(s):Polycystic Ovary Syndrome; InfertilityLast Updated:April 16, 2014Unknown status
7214
A Phase 3 Trial of Epcoritamab vs Investigator’s Choice Chemotherapy in R/R DLBCL
Condition(s):Diffuse Large B-cell LymphomaLast Updated:March 29, 2023Recruiting
7215
Safety/Efficacy Study to Assess Whether FVIII/VWF Concentrate Can Induce Immune Tolerance in Haemophilia A Patients
Condition(s):Hemophilia ALast Updated:June 23, 2015Unknown status
7216
Efficacy of RestoreX Penile Traction Therapy In Preserving Erectile Function Post-Prostatectomy
Condition(s):Erectile Dysfunction Following Radical ProstatectomyLast Updated:March 17, 2022Recruiting
7217
Probiotic Modulation of Oral Microbiota
Condition(s):Microbial ColonizationLast Updated:March 25, 2022Recruiting
7218
Letrozole and Lapatinib Followed by Everolimus in Women With Advanced Breast Cancer
Condition(s):Breast Neoplasms; Endocrine Breast Diseases; Neoplasm MetastasisLast Updated:February 11, 2022Terminated
7219
Better Leukemia Diagnostics Through AI (BELUGA)
Condition(s):Hematologic Malignancy; Leukemia; Minimal Residual Disease; Lymphoma; Blood CancerLast Updated:March 22, 2023Recruiting
7220
Physiologic Adaptations to Interval and Continuous Running at Low Volume and Vigorous Intensity Over 14-Weeks.
Condition(s):Exhaustion – PhysiologicalLast Updated:April 29, 2014Completed